BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1573403)

  • 1. Muscarinic binding of pial vessels and arachnoid membrane.
    Lasbennes F; Verrecchia C; Philipson V; Seylaz J
    J Neurochem; 1992 Jun; 58(6):2230-5. PubMed ID: 1573403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic cholinergic receptor sites in cerebral blood vessels.
    Estrada C; Krause DN
    J Pharmacol Exp Ther; 1982 Apr; 221(1):85-90. PubMed ID: 7062294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarine binding sites in bovine adrenal medulla.
    Barron BA; Murrin LC; Hexum TD
    Eur J Pharmacol; 1986 Mar; 122(2):269-73. PubMed ID: 3709656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic cholinoceptors in native and cultured human corneal endothelium.
    Walkenbach RJ; Ye GS; Boney F; Dueker DK
    Curr Eye Res; 1993 Feb; 12(2):155-62. PubMed ID: 8449026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptors of the vascular bed: radioligand binding studies on bovine splenic veins.
    Brunner F; Kukovetz WR
    J Cardiovasc Pharmacol; 1986; 8(4):712-21. PubMed ID: 2427809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two polypeptides from Dendroaspis angusticeps venom selectively inhibit the binding of central muscarinic cholinergic receptor ligands.
    Jerusalinsky D; Cerveñasky C; Peña C; Raskovsky S; Dajas F
    Neurochem Int; 1992 Feb; 20(2):237-46. PubMed ID: 1304863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic muscarinic receptors in rat cochlea.
    van Megen YJ; Klaassen AB; Rodrigues de Miranda JF; Kuijpers W
    Brain Res; 1988 Nov; 474(1):185-8. PubMed ID: 3214711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
    Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M
    Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinities of pirenzepine for muscarinic cholinergic receptors in membranes isolated from bovine tracheal mucosa and smooth muscle.
    Madison JM; Jones CA; Tom-Moy M; Brown JK
    Am Rev Respir Dis; 1987 Mar; 135(3):719-24. PubMed ID: 3826897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvessels isolated from brain: localization of muscarinic sites by radioligand binding and immunofluorescent techniques.
    Moro V; Kacem K; Springhetti V; Seylaz J; Lasbennes F
    J Cereb Blood Flow Metab; 1995 Nov; 15(6):1082-92. PubMed ID: 7593341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic characterization of muscarinic receptors of insect brains.
    Abdallah EA; Eldefrawi ME; Eldefrawi AT
    Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
    J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
    Gao ZG; Liu CG
    Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.
    Vanderheyden P; Ebinger G; Vauquelin G
    Biochem Pharmacol; 1987 Dec; 36(23):4119-24. PubMed ID: 3689439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of muscarinic receptor subtypes in cerebral blood vessels.
    Garcia-Villalon AL; Krause DN; Ehlert FJ; Duckles SP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):304-10. PubMed ID: 1649298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor subtype in porcine coronary artery.
    Yamada S; Yamazawa T; Harada Y; Yamamura HI; Nakayama K
    Eur J Pharmacol; 1988 Jun; 150(3):373-6. PubMed ID: 3416915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.